Purchase Order 75N95019P00221

This firm fixed-price purchase order, valued at $10,900, was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Pointcare Systems Inc. R&D Division, doing business as Chirosolve, for the synthesis of tert-butyl (R)-3-(5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)piperidine-1-carboxylate in a 75 gram quantity with over 95% purity. The solicitation sought synthesis and delivery of the specified intermediate...

This is a firm fixed-price purchase order contract awarded by the U.S. Army's Research, Development and Engineering Command (RDECOM) to CEM Corporation, a small business manufacturer of laboratory equipment. The contract, valued at $110,032.00, is for the delivery of a Liberty Blue 2.0 peptide synthesizer. The contract is set aside for small businesses and has a completion date of June 30, 2025. CEM Corporation holds a Multiple Award Schedule (MAS) contract with the General Services...

<p>This federal contract, awarded by the National Center for Advancing Translational Sciences, a civilian agency, to A1 Biochem Labs LLC, provides for the non-GMP scale up synthesis of a specific chemical compound. The contract is a firm fixed price purchase order with a ceiling value of $24,852.00 and a completion date of October 17, 2024. The contract does not have a set-aside designation. No information is provided about any subcontractors involved in this effort.</p>

This is a delivery order awarded by the National Institute on Drug Abuse (part of the National Institutes of Health under the Department of Health and Human Services) to Bachem Americas, Inc., a foreign-owned for-profit manufacturer of pharmaceutical ingredients. The $1,050,039.90 firm fixed-price contract is for the manufacture of 200 grams of current Good Manufacturing Practice (cGMP) parathyroid hormone-related protein (PTH-rP). The work is being conducted under the parent &quot;CRO Support...

This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Synovel Laboratory LLC, a self-certified small disadvantaged business and limited liability company. The contract was for the synthesis of 100 grams of the chemical compound NCGC00413972, with a period of performance from June 23, 2021 to August 22, 2021. The contract was awarded on a firm fixed price basis with a...

The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs....

<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>

The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...

This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their...

This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED for the acquisition of 15 grams of PT-2977 (CAS: 1672668-24-4) with a chemical purity exceeding 95% and enantiopurity exceeding 95%. The contract has a ceiling value of $24,800.00 and a completion date of July 8, 2020. This award is not associated with any set-aside program. Wuxi...